Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin and Tadalafil for Overactive Bladder in Females
NCT07312955Completed
- Sponsor
- Ain Shams University
- Start
- May 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tadalafil in overactive bladder (OAB) (2 arms), sponsored by Ain Shams University. Primary endpoint: Overactive Bladder Symptom Score at 1 month. Started May 2025; status: completed.
02
Drugs
tadalafil
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07312955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07312955.